Page last updated: 2024-08-22

ddms and 8,11,14-eicosatrienoic acid

ddms has been researched along with 8,11,14-eicosatrienoic acid in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brand-Schieber, E; Falck, JF; Schwartzman, M1
Carroll, MA; Falck, JR; McGiff, JC; Pomposiello, SI1
Campbell, WB; Endsley, MP; Falck, JR; Gross, ER; Gross, GJ; Isbell, MA; Moore, JM; Nithipatikom, K1
Falck, JR; Gross, GJ; Isbell, MA; Moore, JM; Nithipatikom, K1
Certíková Chábová, V; Cervenka, L; Falck, JR; Hammock, BD; Imig, JD; Kompanowska-Jezierska, E; Kopkan, L; Kramer, HJ; Kujal, P; Sadowski, J; Vanecková, I; Vanourková, Z; Vernerová, Z; Walkowska, A1

Other Studies

5 other study(ies) available for ddms and 8,11,14-eicosatrienoic acid

ArticleYear
Selective inhibition of arachidonic acid epoxidation in vivo.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2000, Volume: 51, Issue:4 Pt 1

    Topics: 8,11,14-Eicosatrienoic Acid; Amides; Animals; Arachidonic Acid; Chromatography, High Pressure Liquid; Cyclodextrins; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fatty Acids, Unsaturated; Humans; Immunoblotting; Kidney; Male; Miconazole; Microsomes; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Sulfones

2000
Epoxyeicosatrienoic acid-mediated renal vasodilation to arachidonic acid is enhanced in SHR.
    Hypertension (Dallas, Tex. : 1979), 2001, Volume: 37, Issue:3

    Topics: 5,8,11,14-Eicosatetraynoic Acid; 8,11,14-Eicosatrienoic Acid; Acetylcholine; Amides; Animals; Arachidonic Acid; Enzyme Inhibitors; Hypertension; Indomethacin; Male; Nitroprusside; Perfusion; Pressure; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Renal Circulation; Sulfones; Tin Compounds; Vasodilation

2001
Inhibition of cytochrome P450omega-hydroxylase: a novel endogenous cardioprotective pathway.
    Circulation research, 2004, Oct-15, Volume: 95, Issue:8

    Topics: 8,11,14-Eicosatrienoic Acid; Amides; Animals; Arachidonic Acids; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dogs; Fatty Acids, Unsaturated; Female; Hydroxyeicosatetraenoic Acids; Isoenzymes; Male; Miconazole; Microsomes; Mixed Function Oxygenases; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Sulfones

2004
Epoxyeicosatrienoic acids in cardioprotection: ischemic versus reperfusion injury.
    American journal of physiology. Heart and circulatory physiology, 2006, Volume: 291, Issue:2

    Topics: 8,11,14-Eicosatrienoic Acid; Amides; Animals; Arachidonic Acid; Cardiotonic Agents; Coronary Circulation; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dogs; Enzyme Inhibitors; Hemodynamics; Hydroxyeicosatetraenoic Acids; Mixed Function Oxygenases; Myocardial Ischemia; Myocardial Reperfusion Injury; Spectrometry, Mass, Electrospray Ionization; Sulfones

2006
Combined inhibition of 20-hydroxyeicosatetraenoic acid formation and of epoxyeicosatrienoic acids degradation attenuates hypertension and hypertension-induced end-organ damage in Ren-2 transgenic rats.
    Clinical science (London, England : 1979), 2010, Feb-23, Volume: 118, Issue:10

    Topics: 8,11,14-Eicosatrienoic Acid; Amides; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Drug Evaluation, Preclinical; Hydroxyeicosatetraenoic Acids; Hypertension; Male; Multiple Organ Failure; Norepinephrine; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Renal Circulation; Sulfones; Vasoconstrictor Agents

2010